A multicenter randomized double-blind comparison of Remifentanil and Alfentanil during total intravenous anaesthesia for out-patient laparoscopic gynaecological procedures

Journal of the Medical Association of Thailand

Volumn 83, Issue 11, 2000, Pages 1324-1332

  Chinachoti, Itima ^a   Suksompong, Sirilak ^a   Kitsampanwong, Wasana ^a   Srivajana, Nutchira ^b   Chainchop, Phetcharee ^a   Chansermkit, Rattana ^b   Rengkosum, Premjit ^a   Suwatcharaphan, Phenpuck ^c   Werawatganon, Tewarug ^b   Techanivate, Anchalee ^b   Tansui, Rassanee ^a   Silapadech, Aurasa ^a   Noocharoen, Pensri ^a   Chatkitcharoen, Nattaya ^b   Chaiyakul, Anong ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Out Patient; Remifentanil; Total Intravenous Anaesthesia

Indexed keywords

ALFENTANIL; ATRACURIUM; FENTANYL; NAPROXEN; PROPOFOL; REMIFENTANIL;

ADULT; AMBULATORY SURGERY; ANESTHETIC RECOVERY; ARTICLE; BOLUS INJECTION; BRADYCARDIA; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS ANESTHESIA; LAPAROSCOPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; ORTHOSTATIC HYPOTENSION; POSTOPERATIVE PAIN; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SURGICAL STRESS; THAILAND; URINE RETENTION; VOMITING;

ADOLESCENT; ADULT; AGED; ALFENTANIL; AMBULATORY SURGICAL PROCEDURES; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; DOUBLE-BLIND METHOD; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; MIDDLE AGED; PIPERIDINES;

EID: 14344276167     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Glass PSA, Hardman D, Kamiyame Y, et al. Preliminary pharmacokinetics and pharmacodynamics of ultra short-acting opioid: remifentanil. Anesth Analg 1993; 77: 1031-40.
2. Feldman PL, James MK, Brackeen MF, et al. Design, synthesis, and pharmacological evaluation of ultrashort to long acting opioid analgesics. J Med Chem 1991; 34: 2202-8.
3. Hoke JF, Shlugman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteer. Anesthesiology 1997 ; 87 : 533-41.
4. Dershwitz M, Hoke JF, Rosow CE. Pharmacokinetic and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996 ; 84: 812-20.
5. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology 1997 ; 86 : 10-23.
6. Minto CF, Schnider TW, Shafer SL. Pharmacokinetic and pharmacodynamics of remifentanil. Anesthesiology 1997; 86: 24-33.
7. Yarmush J, D'Angelo R, Kirkhart B, et al. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology 1997 ; 87: 235-43.
8. Avramov MN, Smith I, White PF. Interaction between midazolam and remifentanil during monitored anesthetic care. Anesthesiology 1996; 85: 1283-9.
9. Harstem A, Gillberg L. Intubation conditions provided by propofol and alfentanil-acceptable, but not ideal : Acta Anesthesiologica Scandinavica 1997; 41: 985-7.
10. Cunningham FE, Hoke JF, Muir KT, et al. Pharmacokinetic/pharmacodynamic evaluation of remifentanil ,GR90291, and alfentanil. Anesthesiology 1995; 83(3A): A376.
11. Cartwright DP, Kvalsvik O, Cassuto J, et al. A randomised blind comparison of remifentanil and alfentanil during anesthesia for outpatient surgery. Anesth Analg 1997; 85: 1014-9.
12. Fortier J, Chung F, Moote C et al. Remifentanil vs alfentanil for ambulatory surgery using preoperative naproxen Na for pain management. Anesthesiology 1997; 87 (3A) : A15.
13. Schuttler J, Albrecht S, Brei H, et al. A comparison of remifentanil and alfentanil in patients dergoing major abdominal surgery. Anaesthesia 1997; 52: 307-17.
14. Rajiv J, Pradip J, Randall B, et al. Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology 1997, 87; 253-9.
15. Jaap V, Toine L, Frank E, et al. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology 1995; 83 : 8-22.
16. Pavlin DJ, Coda B, Shen DD, et al. Effects of combining propofol and alfentanil on ventilation, analgesia, sedation and emesis in human volunteers; Anaesthesiology 1996; 84 : 23-37.
17. Atul K, Peter G, James RJ, et al. Measured context sensitive half-times of remifentanil and alfentanil. Anesthesiology1995; 83 : 968-95.
18. Donale RM, Philip GB, Raymond JM, Kathryn AH. Midazolam and awareness with recall during total intravenous anaesthesia. Can J of Anaesth 1996; 43, 946-53.
19. Michael S, Wojciech BD, John MM, et al. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White. Syndrome during alfentanil/midazolam anesthesia : Anesthesiology 1995 ; 82: 888-95.
20. Chinachoti T, Montraporn N, Shalanavin V, et al. Total intravenous deep sedation for radio-frequency intracardiac catheter ablation. Thai Journal of Anesthesiology 1996: 166-72.
21. Song D, White PF. Optimal dose of remifentanil for maintaining hemodynamic stability during anesthetic induction and tracheal intubation : A comparison with fentanyl. Anesth Analg 1998; 86 (2suppl) S105.